Global Pathology Analysis & Statistics, August 2014 (p2)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

You might be interested in: cancer, breast cancer, leukemia, more »

31-80 of about 1 800 reports

Purchase Reports From Reputable Market Research Publishers

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Bosatria (Mepolizumab) (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Bosatria (Mepolizumab) (Asthma) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023

Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Lebrikizumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Benralizumab (Asthma) - Forecast and Market Analysis to 2023

Benralizumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Benralizumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Benralizumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Dupilumab (Asthma) - Forecast and Market Analysis to 2023

Dupilumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Dupilumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Dupilumab (Asthma) - Forecast and Market Analysis to 2023”. The ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Quilizumab (Asthma) - Forecast and Market Analysis to 2023

Quilizumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Quilizumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Quilizumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Tralokinumab (Asthma) - Forecast and Market Analysis to 2023

Tralokinumab (Asthma) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • August 2014
  • by Global Data

Tralokinumab (Asthma) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Tralokinumab (Asthma) - Forecast and Market Analysis to 2023”. ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Brilinta (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Brilinta (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Effient (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Effient (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Crestor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Crestor (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe
Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Xarelto (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Xarelto (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Angiomax (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Angiomax (Acute Coronary Syndrome) - Forecast and ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, United Kingdom, Europe
Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Cangrelor (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe
Zontivity (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Zontivity (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Zontivity (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Zontivity (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Alirocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Alirocumab (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Evolocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Evolocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Evolocumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Evolocumab (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Bococizumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Bococizumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Bococizumab (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Bococizumab (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Anacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Anacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Anacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Anacetrapib (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • July 2014
  • by Global Data

Evacetrapib (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Evacetrapib (Acute Coronary Syndrome) - Forecast ...

  • Industries : Pathology
  • Countries : World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe
Global Influenza Market 2014-2018

Global Influenza Market 2014-2018

  • $ 3 000
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Influenza Influenza is a contagious respiratory disease caused by influenza viruses. These viruses infect the nose, throat, and lungs causing mild to severe illness. The disease can be fatal in some ...

  • Industries : Pathology
  • Countries : World
North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

North America Autoimmune Diagnostics Market - Growth, Trends And Forecasts (2014 - 2019)

  • $ 3 000
  • Industry report
  • September 2014
  • by Mordor Intelligence LLP

North America autoimmune disease diagnostics market is estimated to reach $7.09 billion in 2020 from $5.504 billion in 2014 with a CAGR 5.24%. The term “autoimmune disease” ...

  • Industries : Pathology
  • Countries : North America
Global Hepatitis C Market 2014-2018

Global Hepatitis C Market 2014-2018

  • $ 3 000
  • Industry report
  • September 2014
  • by Infiniti Research Limited

About Hepatitis C Hepatitis C is a liver disease caused by infection due to hepatitis C virus. Hepatitis C infection predominantly affects the liver; however, other parts of the body are also affected ...

  • Industries : Pathology
  • Countries : World
North America Hernia Repair Market Outlook to 2020

North America Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • July 2014
  • by Global Data

North America Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "North America Hernia Repair Market Outlook to 2020", provides key market data on the North America Hernia Repair market. ...

  • Industries : Pathology
  • Countries : North America, Mexico, Canada, United States
EU5 Hernia Repair Market Outlook to 2020

EU5 Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • July 2014
  • by Global Data

EU5 Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "EU5 Hernia Repair Market Outlook to 2020", provides key market data on the EU5 Hernia Repair market. The report provides value, ...

  • Industries : Pathology
  • Countries : United Kingdom, Spain, Italy, France, Germany, Europe
Asia-Pacific Hernia Repair Market Outlook to 2020

Asia-Pacific Hernia Repair Market Outlook to 2020

  • $ 3 000
  • Industry report
  • July 2014
  • by Global Data

Asia-Pacific Hernia Repair Market Outlook to 2020 Summary GlobalData's new report, "Asia-Pacific Hernia Repair Market Outlook to 2020", provides key market data on the Asia-Pacific Hernia Repair market. ...

  • Industries : Pathology
  • Countries : South Korea, Australia, Japan, India, China, Asia, World, Oceania
PharmaPoint: Asthma - Current and Future Players

PharmaPoint: Asthma - Current and Future Players

  • $ 2 995
  • Industry report
  • August 2014
  • by Global Data

PharmaPoint: Asthma - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Asthma - Current and Future Players”. The report is a vital source of up-to-date information ...

  • Industries : Pathology
  • Countries : World
PharmaPoint: Acute Coronary Syndrome - Current and Future Players

PharmaPoint: Acute Coronary Syndrome - Current and Future Players

  • $ 2 995
  • Industry report
  • July 2014
  • by Global Data

PharmaPoint: Acute Coronary Syndrome - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Acute Coronary Syndrome - Current and Future Players”. The report ...

  • Industries : Pathology
  • Countries : World
Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2014-2024 : Opportunities for Leading Companies

Alzheimer's Disease Therapeutics and Diagnostics Market Forecast 2014-2024 : Opportunities for Leading Companies

  • $ 3 013
  • Industry report
  • August 2014
  • by Visiongain

Report Details Alzheimer's medicine - your guide to technologies, trends and revenues Where is the Alzheimer's disease treatment market heading? Visiongain's new report gives you revenue predictions fo ...

  • Industries : Pathology
  • Countries : United States, World, Europe, Italy, Japan, France, China, Brazil, United Kingdom, Spain, Russian Federation, Germany, India
Global Glaucoma Devices Market 2014-2018

Global Glaucoma Devices Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Glaucoma Glaucoma is a long-lasting, permanent condition that does not cause immediate blindness. Glaucoma is a disease that damages the eye's optic nerve. This disease is often called the “sneak ...

  • Industries : Pathology
  • Countries : World
Global Sexually Transmitted Disease (STD) Testing Market 2014-2018

Global Sexually Transmitted Disease (STD) Testing Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

Sexually transmitted diseases (STDs) can be caused by infections that are passed from one person to another person through sexual contact. It can also be transmitted through nonsexual modes such as from ...

  • Industries : Pathology
  • Countries : World
Global Digital Pathology Market 2014-2018

Global Digital Pathology Market 2014-2018

  • $ 2 500
  • Industry report
  • October 2014
  • by Infiniti Research Limited

About Global Digital Pathology Digital pathology includes managing, interpreting, and analysing the digital information. It also termed as virtual microscopy or virtual pathology. It includes the process ...

  • Industries : Pathology
  • Countries : World
About 4 700 reports

Download Unlimited Documents from Trusted Public Sources

Global Pathology Description

  • Flu Express
  • October 2014
    4 pages
  • Influenza  

  • World  

    United Kingdom  

    China  

View report >

55 Companies

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

GlaxoSmithKline P.L.C.

United States

AstraZeneca PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.